
Back on Track: Achieving Healthy Weight Loss is a podcast that focuses on helping people get back on track and stay on track with their weight loss journey. This podcast focuses on improving your Mindset, Motivation and Momentum in your weight loss journey.
Can medications like Ozempic, Wegovy, and Zepbound change how much you want to drink alcohol? Emerging research suggests they may. GLP-1 medications, particularly semaglutide, may influence the brain's reward system, reduce alcohol cravings, and help some people reduce heavy drinking. In this episod...
Can obesity affect your ability to get pregnant? The answer is yes, but it doesn't mean you cannot conceive. Obesity can influence hormone regulation, insulin sensitivity, ovulation, and reproductive health in both women and men. In this episode, I explain how obesity can affect fertility, why insul...
A study of Black women diagnosed with breast cancer found that those with the highest intake of ultra-processed foods had a 40% higher relative rate of breast cancer mortality than those with the lowest intake. What does that finding mean, and what should we take away from it? In this episode, I e...
Weight gain during perimenopause and menopause is not simply a matter of eating less or exercising more. Hormonal changes, shifts in body composition, muscle loss, sleep, stress, and metabolic health can all play a role in how your body changes during this stage of life. In this episode of Back on T...
Losing weight is only part of the goal. Preserving muscle, maintaining strength, and improving your overall health matter just as much. In this episode, I’m discussing why muscle preservation deserves more attention during weight loss, particularly as GLP-1 medications like semaglutide and tirzepati...
If someone tells you, “It’s just a peptide,” that should be the beginning of the conversation, not the end. Peptides are chains of amino acids, but the word tells you very little about what you're actually taking. It doesn't tell you whether something is a supplement, medication, investigational dru...
Obesity treatment may be moving beyond weekly injections. In this episode, I’m taking a closer look at Maritide, an investigational obesity medication that is still being studied and is not FDA approved for the treatment of obesity. What makes Maritide particularly interesting is that it takes a dif...
Have you noticed that your body seems to be changing even though you haven’t changed what you’re doing? Maybe the weight is starting to settle around your middle. Your sleep isn't what it used to be. You're struggling to maintain muscle, your energy feels different, and suddenly the things that work...
You’re taking a GLP-1 medication, but the scale isn’t moving the way you expected. Maybe you’ve even watched someone else say they lost 20 pounds in two months and wondered, “Why isn’t this working for me?” If you’ve been asking yourself that question, I want you to know that your experience with a ...
Have you ever wondered whether compounded GLP-1 medications are as safe and effective as brand-name medications? Or how you can tell if a GLP-1 or peptide product is fake? In this episode of Back on Track: Achieving Healthy Weight Loss, I’m continuing my Ask the Obesity Doctor series, where I answer...
What questions do you have about GLP-1 medications and weight loss? In this episode of Back on Track: Achieving Healthy Weight Loss, I’m doing something a little different. I’m answering five real questions that viewers have left on my YouTube videos and social media about weight loss medications. I...
One month into the Medicare GLP-1 Bridge program, I've learned that getting approved is less complicated once you understand the pathway. But there are several important details that can cause delays if you don't know what to look for. In this episode, I walk you through what I've learned from helpi...
Summit night on Kilimanjaro started at 11:40pm in complete darkness, with nothing but a headlamp and the next step in front of me. Nine hours later, I reached the roof of Africa. If you've ever felt like your health journey is moving backward before it moves forward, this episode is for you. In this...
Over a week ago, I stood at 19,341 feet on the roof of Africa, Mount Kilimanjaro. It was the hardest thing I've ever done, harder than any Ironman or marathon. But somewhere between the rainforest and the summit, I realized I wasn't just climbing a mountain. I was watching my patients' weight loss j...
I had a patient walk into my office recently looking frustrated. She sat down, crossed her arms, and said, "Dr. Shelly, my medication has stopped working. I lost 32 pounds, but for the last six weeks my weight hasn't budged. Am I immune to this medication?" If you've looked at the scale lately and w...
"Doc, do I need to take this forever?" It's one of the most common questions I hear in my office, whether it's someone's very first visit or someone who's already lost 30, 40, even 80 pounds and is feeling great. In this episode, I break down why your body fights so hard to regain weight after you l...
If you've seen headlines linking Ozempic and other GLP-1 medications to sudden eye strokes, I want to stop the panic right here. In this episode, I break down what the research on NAION actually shows, who's really at risk, and why the scary relative-risk numbers you're seeing online don't tell the...
I hear this from so many of my patients: "Dr. Shelly, I haven't changed anything—not my diet, not my exercise—but I'm gaining weight and my body just doesn't respond the way it used to." If you're a woman in your 40s or 50s, you're probably nodding right now. In this episode, I'm walking you through...
A patient asked me this recently: "Dr. Shelley, I've heard that GLP-1 medications can cause muscle loss. Does that mean they can hurt my bones too?" It's an excellent question—and one we don't talk about nearly enough. In this episode, I'm walking you through what the research actually shows about G...
Can retatrutide finally be the breakthrough obesity treatment we've been waiting for? The answer is yes—and the data is stunning. In this episode I'm walking you through the biggest obesity medicine discovery from the ADA's 86th Scientific Session: retatrutide, a triple hormone receptor agonist show...